79 related articles for article (PubMed ID: 21460417)
1. Beta-3 agonist-induced lipolysis and nitric oxide production: relationship to PPARgamma agonist/antagonist and AMP kinase modulation.
Hodis J; Vaclavíková R; Farghali H
Gen Physiol Biophys; 2011 Mar; 30(1):90-9. PubMed ID: 21460417
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide production from rat adipocytes is modulated by beta3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes.
Canová NK; Lincová D; Kmonícková E; Kameníková L; Farghali H
Nitric Oxide; 2006 May; 14(3):200-11. PubMed ID: 16413212
[TBL] [Abstract][Full Text] [Related]
3. Inconsistent role of nitric oxide on lipolysis in isolated rat adipocytes.
Canová N; Lincová D; Farghali H
Physiol Res; 2005; 54(4):387-93. PubMed ID: 15588153
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes.
Kim J; Oh YS; Shinn SH
Exp Eye Res; 2005 Jul; 81(1):65-70. PubMed ID: 15978256
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice.
Seto SW; Lam TY; Leung GP; Au AL; Ngai SM; Chan SW; Kwan YW
Eur J Pharmacol; 2007 Oct; 572(1):40-8. PubMed ID: 17603034
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.
Cho DH; Choi YJ; Jo SA; Jo I
J Biol Chem; 2004 Jan; 279(4):2499-506. PubMed ID: 14593122
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes.
Bordicchia M; Pocognoli A; D'Anzeo M; Siquini W; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Sarzani R
J Hypertens; 2014 Feb; 32(2):389-96. PubMed ID: 24256707
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats.
Dobashi K; Asayama K; Nakane T; Kodera K; Hayashibe H; Nakazawa S
Life Sci; 2000 Sep; 67(17):2093-101. PubMed ID: 11057759
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide.
Crosby MB; Svenson JL; Zhang J; Nicol CJ; Gonzalez FJ; Gilkeson GS
J Pharmacol Exp Ther; 2005 Jan; 312(1):69-76. PubMed ID: 15356214
[TBL] [Abstract][Full Text] [Related]
10. Short-term regulation of tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes is mediated through the inducible nitric oxide synthase/nitric oxide-dependent pathway.
Lien CC; Au LC; Tsai YL; Ho LT; Juan CC
Endocrinology; 2009 Nov; 150(11):4892-900. PubMed ID: 19819972
[TBL] [Abstract][Full Text] [Related]
11. Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types.
Hollenga C; Brouwer F; Zaagsma J
Eur J Pharmacol; 1991 Aug; 200(2-3):325-30. PubMed ID: 1685995
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of beta3-adrenergic receptor-stimulated adenylyl cyclase activity and lipolysis in rats.
Vicario PP; Candelore MR; Schaeffer MT; Kelly L; Thompson GM; Brady EJ; Saperstein R; MacIntyre DE; Tota LM; Cascieri MA
Life Sci; 1998; 62(7):627-38. PubMed ID: 9472722
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor subtypes mediating lipolysis in porcine adipocytes. Studies with BRL-37344, a putative beta3-adrenergic agonist.
Mills S
Comp Biochem Physiol C Toxicol Pharmacol; 2000 May; 126(1):11-20. PubMed ID: 11048660
[TBL] [Abstract][Full Text] [Related]
14. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Xiao Y; Yuan T; Yao W; Liao K
FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol feeding suppresses beta-adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat.
Kang L; Nagy LE
Endocrinology; 2006 Sep; 147(9):4330-8. PubMed ID: 16794014
[TBL] [Abstract][Full Text] [Related]
16. The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils.
Matsuwaki Y; Ueki S; Adachi T; Oyamada H; Kamada Y; Yamaguchi K; Kanda A; Hamada K; Kayaba H; Chihara J
Pharmacology; 2005 Jul; 74(4):169-73. PubMed ID: 15818060
[TBL] [Abstract][Full Text] [Related]
17. The acid metabolite of ZD7114 is a partial agonist of lipolysis mediated by the rat beta 3-adrenoceptor.
Mayers RM; Quayle SP; Thompson AJ; Grant TL; Holloway BR
Eur J Pharmacol; 1996 Jan; 295(2-3):199-205. PubMed ID: 8720584
[TBL] [Abstract][Full Text] [Related]
18. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes.
Hoffstedt J; Lönnqvist F; Shimizu M; Blaak E; Arner P
Int J Obes Relat Metab Disord; 1996 May; 20(5):428-34. PubMed ID: 8696421
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
